[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100412328":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":26,"centralContacts":31,"locations":43,"responsibleParty":56,"collaborators":58,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":65,"acronym":66,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":25,"maxAge":25,"enrollmentInfo":69,"targetDuration":25,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":25,"overallStatus":45,"whyStopped":25,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Royal North Shore Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"standard","ACTIVE_COMPARATOR","standard radiotherapy 5 fractions",[13],"Radiation: dose escalation",{"label":15,"type":16,"description":17,"interventionNames":18},"single fraction dose escalation","EXPERIMENTAL","8Gy to Planned Target Volume, 12Gy to Clinical Target Volume +\u002F- 14Gy to Gross Target Volume",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"RADIATION","dose escalation","single fraction dose escalation to the tumour",[15,9],null,[27],{"name":28,"affiliation":29,"role":30},"Thomas Eade","Northern Sydney Cancer Centre, Royal North Shore Hospital","PRINCIPAL_INVESTIGATOR",[32,38],{"name":33,"role":34,"phone":35,"phoneExt":36,"email":37},"Carol Kwong, RN","CONTACT","+61294631339","31339","carolyn.kwong@health.nsw.gov.au",{"name":39,"role":34,"phone":40,"phoneExt":41,"email":42},"Heidi Tsang, RN","+61294631340","31340","heidi.tsang@health.nsw.gov.au",[44],{"facility":5,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":25,"geoPoint":25,"contacts":51},"RECRUITING","Saint Leonards","New South Wales","2065","Australia","AU",[52,53,54],{"name":33,"role":34,"phone":35,"phoneExt":36,"email":37},{"name":39,"role":34,"phone":40,"phoneExt":41,"email":42},{"name":55,"role":30,"phone":25,"phoneExt":25,"email":25},"Thomas Eade, MBBS",{"type":57,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[59],{"name":60,"class":6},"Northern Sydney and Central Coast Area Health Service","100412328","advanced-techniques-for-single-fraction-palliative-radiotherapy-versus-standard-multi-fraction-radiation-100412328",false,"NCT04649125","Advanced Techniques For Single-fraction Palliative Radiotherapy Versus Standard Multi Fraction Radiation","ASPIRE_Multi","Inclusion Criteria:\n\n* Metastatic cancer\n* Recommended for 5-10 fractions palliative radiation\n* Patients with spinal cord compression are eligible for enrolment\n\nExclusion Criteria:\n\n* Unwilling or unable to give informed consent\n* Patients who are recommended for single fraction palliative radiation","ALL",{"count":70,"type":71},100,"ESTIMATED","INTERVENTIONAL",[74],"NA","The aim of the study is to determine if single fraction dose escalated palliative radiotherapy results in a prolonged duration of benefit for patients otherwise suitable for Multifraction (5-10#) palliative radiation. The primary endpointis to determine the percentage of patients who have achieved a substantial benefit from palliative radiotherapy and have not redeveloped symptoms by 12 months post treatment",[77],"Palliative Radiotherapy","2026-02-04",{"date":80,"type":81},"2026-02-06","ACTUAL",{"date":83,"type":81},"2021-05-31",{"date":85,"type":71},"2026-06-30",{"name":5,"class":6},1]